<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Vet World</journal-id><journal-id journal-id-type="iso-abbrev">Vet World</journal-id><journal-title-group><journal-title>Veterinary World</journal-title></journal-title-group><issn pub-type="ppub">0972-8988</issn><issn pub-type="epub">2231-0916</issn><publisher><publisher-name>Veterinary World</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29263596</article-id><article-id pub-id-type="pmc">5732340</article-id><article-id pub-id-type="doi">10.14202/vetworld.2017.1337-1342</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Effects of hyperbaric therapy on liver morphofunctional of rabbits (<italic>Oryctolagus cuniculus</italic>) after hind limb ischemia-reperfusion injury</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lukiswanto</surname><given-names>Bambang Sektiari</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Yuniarti</surname><given-names>Wiwik Misaco</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Motulo</surname><given-names>Y. Yosis</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Veterinary Clinic, Faculty of Veterinary Medicine, Universitas Airlangga, Jl. Mulyorejo, Kampus C, Surabaya 60115, Indonesia</aff><aff id="aff2"><label>2</label>Department of Surgery, Division of Thoracic, Cardiac, and Vascular Surgery, Dr. Soetomo General Hospital, Surabaya 60115, Indonesia</aff><author-notes><corresp id="cor1"><bold>Corresponding author:</bold> Bambang Sektiari Lukiswanto, e-mail: <email xlink:href="bamsekti@yahoo.com">bamsekti@yahoo.com</email><bold>Co-authors:</bold> WMY: <email xlink:href="wiwikmisaco@wiwikmisaco.yahoo">wiwikmisaco@wiwikmisaco.yahoo</email>, YYM: <email xlink:href="yosis_motulo@yahoo.com">yosis_motulo@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>11</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>14</day><month>11</month><year>2017</year></pub-date><volume>10</volume><issue>11</issue><fpage>1337</fpage><lpage>1342</lpage><history><date date-type="received"><day>11</day><month>6</month><year>2017</year></date><date date-type="accepted"><day>18</day><month>10</month><year>2017</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Lukiswanto, <italic>et al</italic>.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p><!--CREATIVE COMMONS-->Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract><sec id="st1"><title>Aim:</title><p>The objective of this research was to study and to prove the effectiveness of hyperbaric oxygen therapy (HBOT) starting time on liver morphofunctional changes after ischemia-reperfusion in the hind limb of rabbits.</p></sec><sec id="st2"><title>Materials and Methods:</title><p>This research used a complete randomized design with 4 groups and 6 repetitions on each. After 6 h artery femoral is ligation, reperfusion was performed for 100 min (G1), HBOT for 90 min after 10 min reperfusion (G2), 10 min reperfusion (G3), and HBOT 90 min after 60 min reperfusion (G4). Then, all of the rabbits were sacrificed. The liver and blood were taken for histopathological changes examination as well as for measuring the level of aspartate aminotransferase (AST) and alanine aminotransferase (ALT). The statistical test using Kruskal&#x02013;Wallis and Mann&#x02013;Whitney showed that the score of degeneration, necrosis, and portal inflammation in groups without HBOT (G1 and G3) were not significantly different, as well as in group with HBOT (G2 and G4) (p&#x0003e;0.05). However, the scores of histopathological changes in G1 and G3 were significantly different from those in G2 and G4 (p&#x0003c;0.05). The levels of AST and ALT in the groups without hyperbaric therapy (G1 and G3) were not significantly different from those in the groups treated with hyperbaric therapy (G2 and G4) (p&#x0003e;0.05).</p></sec><sec id="st3"><title>Result::</title><p>Hind limb ischemia injury reperfusion can trigger damage for liver morphology, but not lead to liver dysfunction. Reperfusion can trigger increased activity of neutrophils, while neutrophil infiltration in the organ will lead to dysfunction. HBOT can inhibit the activity of neutrophils and the dysfunction of organs caused by ischemic reperfusion.</p></sec><sec id="st4"><title>Conclusion:</title><p>HBOT for 90 min, both 10 and 60 min after the reperfusion, can protect hepatocytes from damage.</p></sec></abstract><kwd-group><kwd>hyperbaric oxygen therapy</kwd><kwd>ischemia</kwd><kwd>liver</kwd><kwd>morphofunctional</kwd><kwd>reperfusion</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>Introduction</title><p>Ischemic condition can occur in a wide variety of disease status. Nevertheless, an ischemic condition often occurs in a variety of surgical procedures such as in a surgical process of vascular or organ transplantation. In such circumstances, ischemic injury can occur when blood flow to a tissue is reduced or stopped in a long time, resulting changes in the metabolism of muscles, from aerobic state into anaerobic one. Consequently, adenosine triphosphate (ATP) depletion and calcium (Ca) extracellular transfer into muscle cells occur, leading to abnormalities in metabolism and thrombosis, as well as tissue inflammation [<xref rid="ref1" ref-type="bibr">1</xref>].</p><p>Blood flow improvement (reperfusion) is the main effort to overcome tissue ischemia (ischemia-reperfusion [IR]). However, reperfusion has negative side effects because it can cause damage and impaired organ function when it is not given appropriately. Inappropriate reperfusion then can trigger activation of proinflammatory mediators as well as formation of reactive oxygen species (ROS), resulting injury to the tissue [<xref rid="ref2" ref-type="bibr">2</xref>]. In severe ischemic conditions, excessive inflammatory response after reperfusion can lead to a systemic inflammatory response syndrome and multiple organ dysfunction syndrome (MODS) [<xref rid="ref3" ref-type="bibr">3</xref>]. MODS generally starts from the lungs and then spreads to the liver, gastrointestinal tract, and kidneys. Bone marrow and liver dysfunctions are in the final stages of MODS. Meanwhile, the dysfunction of the nervous system can occur at the beginning or end of MODS [<xref rid="ref4" ref-type="bibr">4</xref>].</p><p>Many researchers actually have already been conducted on the effects of various drugs in reducing the negative impacts of reperfusion. Those previous researchers focused on the impacts of reperfusion used hyperbaric oxygen therapy (HBOT), a method of therapy using 100% oxygen with a high atmospheric pressure in a special room. HBOT has been proved to be very helpful to reduce the negative impacts of reperfusion in various tissues by reducing the activity of mediators of inflammation and oxidative stress induced by the reperfusion process [<xref rid="ref5" ref-type="bibr">5</xref>].</p><p>Unfortunately, there have not been a lot of researchers aimed to know the appropriate time for the administration of HBOT in patients with various organ function disorders after reperfusion, especially its impact on liver organ. In patients with stroke, HBOT is known to be effective if given exactly 3 h after reperfusion since if given more than 3 h, it will not give any effect [<xref rid="ref6" ref-type="bibr">6</xref>]. This research aimed to investigate effects of time-based HBOT administration on liver morphofunctional state of rabbits (<italic>Oryctolagus cuniculus</italic>) as animal models after hind limb reperfusion.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>Materials and Methods</title><sec id="sec2-1"><title>Ethical approval</title><p>This research was conducted under the ethical use of laboratory animals and also was approved by the Ethical Committee of Faculty of Veterinary Medicine, Universitas Airlangga.</p></sec><sec id="sec2-2"><title>Research sites</title><p>This research was conducted at the Faculty of Veterinary Medicine, Universitas Airlangga, and also at the Department of Underwater and Hyperbaric Medicine, Hospital Dr. Ramelan, Surabaya. Preparations for histopathological examination and blood tests were made in the Department of Pathology and Veterinary Hospital, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya.</p></sec><sec id="sec2-3"><title>Experimental animals</title><p>Experimental animals used in this research were 24 male New Zealand rabbits aged 6 months old and weighed 2-2.5 kg. Most studies use male animal models because of their stable hormonal status during treatment, and these animals are not at risk of being affected by hormonal (estrogen/progesterone) fluctuation related to the reproductive cycle that may confound the results of the study. Reperfusion injury using the rabbit as animal model showed significantly less infarct in female hearts as compared to males [<xref rid="ref7" ref-type="bibr">7</xref>].</p></sec><sec id="sec2-4"><title>Research materials</title><p>Materials used in this research were mineral water and food for rabbits, 70% alcohol, 10% ketamine, 2% xylazine hydrochloride, atropine sulfate, sterile thump, 10% buffered formalin, materials for staining hematoxylin-eosin (HE), materials for aspartate aminotransferase (AST) and alanine aminotransferase (ALT) examinations, and materials for the euthanasia of rabbits at the end of the research.</p></sec><sec id="sec2-5"><title>Research tools</title><p>Tools used in this research were rabbit hutches, minor surgery equipment, masks, gloves, 10 cc syringe, syringes 3 cc, silastic band, hyperbaric chamber, a place to store organs, light microscope, object, cover glass, as well as blood container tube without anticoagulants.</p></sec><sec id="sec2-6"><title>Experimental animal preparation</title><p>Those rabbits were adapted for 1 week before the research. They were fed and given to drink <italic>ad libitum</italic>. Next, femoral artery ligation was conducted on all the experimental animals. They were then divided into four groups, namely, G1, G2, G3, and G4.</p><p>Afterward, before anesthesia was conducted for surgery, all those rabbits were fasted for 12 h. Next, anesthesia was performed by weighing each rabbit and then injecting them with 0.02 mg/kg of atropine sulfate intramuscularly. After 10 min, anesthesia was carried out by injecting a combination of ketamine-xylazine with doses of 35 mg/kg and 5 mg/kg intramuscularly [<xref rid="ref7" ref-type="bibr">7</xref>].</p><p>Although 30-50% of rabbits produce endogenous atropinase enzymes, because using atropine sulfate 0.1-0.2 mg/kg bw/sc, im. in some studies often helpful to decrease salivary production, bronchial secretion and preventing the occurrence of vagal which can cause bradycardia [<xref rid="ref8" ref-type="bibr">8</xref>].</p><p>After all of those rabbits were anesthetized, an incision was made in the groin area of their sinister. Next, dissection was performed to separate the femoral artery from the nerve and the vein. Ischemia was induced by ligating the femoral artery with silastic band for 6 h, then followed with reperfusion by opening or removing the ligation to restore normal blood circulation in accordance with the treatment group.</p><p>Group 1 (G1): Femoral artery ligation for 6 h, followed with reperfusion by releasing ligation for 100 min (IR 100 min).</p><p>Group 2 (G2): Ligation for 6 h, followed with reperfusion by releasing ligation for 100 min. HBOT was given 10 min after the reperfusion for 90 min (IR 100 min with HBOT 90 min).</p><p>Group 3 (G3): Ligation for 6 h, followed with reperfusion by releasing ligation for 150 min (IR 150 min).</p><p>Group 4 (G4): Ligation for 6 h, followed with reperfusion by releasing ligation for 150 min. Hyperbaric therapy was given 60 min after the reperfusion for 90 min (IR 150 min with HBOT 90 min).</p><p>At the end of the research, all the rabbits were sacrificed. Their liver and blood were taken for examining histopathological changes in their liver using HE staining as well as for measuring the levels of AST and ALT. Histopathological changes were evaluated to assess the degree of liver damage as a result of the treatment given. Scoring method used in this research was a modification of Knodell method [<xref rid="ref9" ref-type="bibr">9</xref>]. The type of the lesions observed and scoring technique used are as following:</p><table-wrap id="T1" position="float"><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1">Type of lesions</th><th align="center" rowspan="1" colspan="1">Score</th><th align="left" rowspan="1" colspan="1">Note</th></tr></thead><tbody><tr><td align="left" rowspan="7" valign="top" colspan="1">Necrosis</td><td align="center" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">No necrosis</td></tr><tr><td align="center" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">Necrosis on 1/3 of lobular</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Necrosis on 1/3-2/3 of lobular</td></tr><tr><td align="center" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">Necrosis on &#x0003e;2/3 of lobular</td></tr><tr><td align="center" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">Necrosis on 1/3-2/3 of lobular+bridging necrosis</td></tr><tr><td align="center" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">Necrosis on &#x0003e;2/3 of lobular+bridgingnecrosis</td></tr><tr><td align="center" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">Multilobular necrosis</td></tr><tr><td align="left" rowspan="4" valign="top" colspan="1">Degeneration</td><td align="center" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">No Degeneration</td></tr><tr><td align="center" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">Degeneration on 1/3 of lobular</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Degeneration on 1/3-2/3 of lobular</td></tr><tr><td align="center" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">Degeneration on &#x0003e;2/3 of lobular</td></tr><tr><td align="left" rowspan="4" valign="top" colspan="1">Portal inflammation</td><td align="center" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">No inflammation</td></tr><tr><td align="center" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">Light inflammation on 1/3 of lobular</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Mild inflammation on 1/3-2/3 of lobular</td></tr><tr><td align="center" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">Severe inflammation on &#x0003e;2/3 of lobular</td></tr><tr><td align="left" rowspan="4" valign="top" colspan="1">Congestion</td><td align="center" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">No hemorrhage</td></tr><tr><td align="center" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">Light (hemorrhage on 1/3 of lobular)</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">Mild (hemorrhage on 1/3-2/3 of lobular)</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Severe (hemorrhage on &#x0003e;2/3 of lobular)</td></tr></tbody></table></table-wrap></sec></sec><sec sec-type="results" id="sec1-3"><title>Results</title><p>Scoring of histopathological changes in the livers was focused on necrotic lesions, degeneration, portal inflammation, and congestion. The results showed that within groups without hyperbaric therapy (G1 and G3), the scores of necrosis, degeneration, and portal inflammation were not significantly different (p&#x0003e;0.05). Similarly, within groups with hyperbaric therapy, namely, G2 and G4, the scores of necrosis, degeneration, and portal inflammation were not significantly different (p&#x0003e;0.05). However, the scores of histopathological changes in G1 and G3 were significantly different from those in G2 and G4 (p&#x0003c;0.05).</p><p>Moreover, scoring results of congestion degree had a different pattern, in which there was no congestion in G1, G2, and G4. Unlike the other three groups, congestion only appeared in G3 (p&#x0003c;0.05) (<xref ref-type="fig" rid="F1">Figure-1</xref>). The degree of the total score (necrosis, degeneration, and portal inflammation) in the group without hyperbaric therapy was higher than in the group with hyperbaric therapy (Figures-<xref ref-type="fig" rid="F2">2</xref>-<xref ref-type="fig" rid="F4">4</xref> and <xref ref-type="table" rid="T1">Table-1</xref>).</p><fig id="F1" position="float"><label>Figure-1</label><caption><p>Congestion on group 3.</p></caption><graphic xlink:href="VetWorld-10-1337-g001"/></fig><fig id="F2" position="float"><label>Figure-2</label><caption><p>Degeneration of hepatocyte on each group.</p></caption><graphic xlink:href="VetWorld-10-1337-g002"/></fig><fig id="F3" position="float"><label>Figure-3</label><caption><p>Necrosis of hepatocyte on each group.</p></caption><graphic xlink:href="VetWorld-10-1337-g003"/></fig><fig id="F4" position="float"><label>Figure-4</label><caption><p>Portal inflammation on each group.</p></caption><graphic xlink:href="VetWorld-10-1337-g004"/></fig><table-wrap id="T2" position="float"><label>Table-1</label><caption><p>Scoring results of histopathological changes in the livers (mean&#x000b1;SD) of each treatment group.</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1">Treatment group</th><th align="center" rowspan="1" colspan="1">Necrosis</th><th align="center" rowspan="1" colspan="1">Degeneration</th><th align="center" rowspan="1" colspan="1">Inflammation portal</th><th align="center" rowspan="1" colspan="1">Congestion</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">G1</td><td align="center" rowspan="1" colspan="1">1.2<sup>b</sup>&#x000b1;0.2</td><td align="center" rowspan="1" colspan="1">1.0<sup>b</sup>&#x000b1;0.0</td><td align="center" rowspan="1" colspan="1">1.1<sup>b</sup>&#x000b1;0.6</td><td align="center" rowspan="1" colspan="1">0.0<sup>a</sup>&#x000b1;0.0</td></tr><tr><td align="left" rowspan="1" colspan="1">G2</td><td align="center" rowspan="1" colspan="1">0.8<sup>a</sup>&#x000b1;0.2</td><td align="center" rowspan="1" colspan="1">0.3<sup>a</sup>&#x000b1;0.1</td><td align="center" rowspan="1" colspan="1">0.5<sup>a</sup>&#x000b1;0.1</td><td align="center" rowspan="1" colspan="1">0.0<sup>a</sup>&#x000b1;0.0</td></tr><tr><td align="left" rowspan="1" colspan="1">G3</td><td align="center" rowspan="1" colspan="1">1.3<sup>b</sup>&#x000b1;0.17</td><td align="center" rowspan="1" colspan="1">0.9<sup>b</sup>&#x000b1;0.5</td><td align="center" rowspan="1" colspan="1">1.1<sup>b</sup>&#x000b1;0.6</td><td align="center" rowspan="1" colspan="1">0.3<sup>b</sup>&#x000b1;0.1</td></tr><tr><td align="left" rowspan="1" colspan="1">G4</td><td align="center" rowspan="1" colspan="1">1.0<sup>a</sup>&#x000b1;0.00</td><td align="center" rowspan="1" colspan="1">0.5<sup>a</sup>&#x000b1;0.1</td><td align="center" rowspan="1" colspan="1">0.6<sup>a</sup>&#x000b1;0.0</td><td align="center" rowspan="1" colspan="1">0.0<sup>a</sup>&#x000b1;0.0</td></tr></tbody></table><table-wrap-foot><fn><p>Means with different superscripts letters are significant at p&#x0003c;0.05. SD=Standard deviation</p></fn></table-wrap-foot></table-wrap><p>Differences in the scoring results of histopathological changes between the groups without hyperbaric therapy, furthermore, did not seem affected by the length of reperfusion duration. For instance, there was no difference in histopathological scoring results and AST/ALT levels between Group G2 and Group G4 although both had different reperfusion duration, namely, 10 and 60 min before the administration of hyperbaric therapy.</p><p>In addition, results of the analysis of AST and ALT levels in each treatment group also showed a different pattern of results derived from the scoring results of histopathological changes in the livers. The results showed that the levels of AST and ALT in the groups without hyperbaric therapy (G1 and G3) were not significantly different from those in the groups treated with hyperbaric therapy (G2 and G4) (p&#x0003e;0.05) (<xref ref-type="table" rid="T2">Table-2</xref>). The levels of AST/ALT in all treatment groups, nevertheless, were still within normal values of AST/ALT levels in rabbits.</p><table-wrap id="T3" position="float"><label>Table-2</label><caption><p>Levels of AST and ALT in each group.</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1">Treatment group</th><th align="center" rowspan="1" colspan="1">AST (IU/L)</th><th align="center" rowspan="1" colspan="1">ALT (IU/L)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">G1</td><td align="center" rowspan="1" colspan="1">36.76<sup>a</sup>&#x000b1;3.11</td><td align="center" rowspan="1" colspan="1">12.60<sup>a</sup>&#x000b1;0.67</td></tr><tr><td align="left" rowspan="1" colspan="1">G2</td><td align="center" rowspan="1" colspan="1">38.08<sup>a</sup>&#x000b1;3.11</td><td align="center" rowspan="1" colspan="1">13.07<sup>a</sup>&#x000b1;0.67</td></tr><tr><td align="left" rowspan="1" colspan="1">G3</td><td align="center" rowspan="1" colspan="1">42.32<sup>a</sup>&#x000b1;3.11</td><td align="center" rowspan="1" colspan="1">12.05<sup>a</sup>&#x000b1;0.67</td></tr><tr><td align="left" rowspan="1" colspan="1">G4</td><td align="center" rowspan="1" colspan="1">40.07<sup>a</sup>&#x000b1;3.11</td><td align="center" rowspan="1" colspan="1">12.30<sup>a</sup>&#x000b1;0.67</td></tr></tbody></table><table-wrap-foot><fn><p>Means with different superscripts letters are significant at p&#x0003c;0.05. AST=Aspartate aminotransferase, ALT=Alanine aminotransferase</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title>Discussion</title><p>Hepatic ischemia-reperfusion injury is a multifactorial pathophysiological process. Numerous studies have shown that this process includes excessive intracellular Ca, increased free oxygen radical, and increased of apoptosis or necrotic liver parenchymal cells [<xref rid="ref10" ref-type="bibr">10</xref>,<xref rid="ref11" ref-type="bibr">11</xref>]. The presence of oxidatives stress caused disturbances in the cell cycle and initiates apoptosis [<xref rid="ref12" ref-type="bibr">12</xref>].</p><p>In this research, necrotic, degenerative, and inflammatory lesions on those livers were not accompanied with changes in the function of those livers by examining the levels of AST/ALT. This may be caused by the degree of hepatocyte damage classified into mild to moderate one. In addition, it can also be caused due to compensatory mechanism owned by those livers, where healthy hepatocytes would take over the function of hepatocytes suffering from the injury.</p><p>Similarly, a previous research also showed that limb ischemia suffered by mice for 2 h, then followed by reperfusion can cause injury to their lungs, but not in their liver and kidneys [<xref rid="ref13" ref-type="bibr">13</xref>]. Unlike in the previous research, other researchers have also shown that limb ischemia suffered by mice for 3 h, then followed by reperfusion can cause injury to their lungs and kidneys, as well as the muscle of their lower limb [<xref rid="ref14" ref-type="bibr">14</xref>,<xref rid="ref15" ref-type="bibr">15</xref>].</p><p>Studies conducted directly with hepatic ischemia-reperfusion injury (HIRI) showed that this treatment cause hepatocytes apoptosis accompanied by elevate levels of AST and ALT, reflect severe hepatocyte damage [<xref rid="ref10" ref-type="bibr">10</xref>,<xref rid="ref11" ref-type="bibr">11</xref>]. These facts support an assumption that many negative effects of IR can trigger ischemia injury to vital organs near the ischemic area. Therefore, it can certainly be said that the improvement in the histopathological feature of G2 and G4 is not due to self-limited, but due to HBOT therapy given since IR was conducted 6 h after the induction of ischemia.</p><p>Vital organs, including liver, are very sensitive to ischemia that occurs on injury due to IR. Ischemia-reperfusion is usually accompanied by oxidative stress and then continued with stimulation of inflammatory response, eventually leading to injury to the liver [<xref rid="ref16" ref-type="bibr">16</xref>]. Oxidation and inflammatory are mediators for the occurrence of injury in various organs after IR, which will end with a dysfunction of the organs, including liver [<xref rid="ref17" ref-type="bibr">17</xref>].</p><p>Various factors, such as oxygen free radicals, migration and activation, abnormalities in the microcirculation, damage to endothelial cells sinusoid, coagulation cascade activation, and Kupffer cell activities to release inflammatory mediators and proteolytic enzymes, plays a role in causing injury to the liver due to IR [<xref rid="ref18" ref-type="bibr">18</xref>,<xref rid="ref19" ref-type="bibr">19</xref>]. Lesions on the liver caused by IR can occur in two phases, causing damage to hepatocytes. First, acute phase is characterized by the production of ROS by Kupffer cells, causing mild injury in the hepatocytes. In the next phase, there will be infiltration of leukocytes to the area of injury as a form of inflammatory cascade commencement. Neutrophil accumulation in the liver may cause injury to hepatocytes through oxidants and proteases released by neutrophils [<xref rid="ref20" ref-type="bibr">20</xref>]. ROS after reperfusion in the initial phase is considered to have an important role in initiating and aggravating oxidative stress in the liver after reperfusion [<xref rid="ref21" ref-type="bibr">21</xref>].</p><p>In this research, furthermore, HBOT could improve morphological function of liver, namely, in Group G2 and Group G4. On the other hand, according to Kihara [<xref rid="ref22" ref-type="bibr">22</xref>], HBOT can trigger increased activity of neutrophils, while neutrophil infiltration in the organ will lead to dysfunction. In such conditions, HBOT can inhibit the activity of neutrophils, and the dysfunction of organs caused.</p><p>Da Silveira <italic>et al</italic>. [<xref rid="ref23" ref-type="bibr">23</xref>] stated that the supply of oxygen after reperfusion can act as a protector of mitochondrial membrane. Oxygen is an agent that plays a role in the formation of ATP by oxidative phosphorylation. The energy generated is very necessary for the flow of both various ions out of the mitochondria as well as liquid into the mitochondria through the mitochondrial membrane. This process then will help to decrease the production and release of ROS, so the mitochondria can function normally. Therefore, an imbalance in this process can make oxidative damage become more extensive. This similar condition was also found in Group G1 and Group G3, experiencing ischemia in the same period without the administration of HBOT.</p><p>Biochemistry profile parameters, including AST/ALT, in rabbits, were influenced by various factors such as breed, age, sex, feed, liver disease, environmental conditions, stress, pregnancy, and heart rhythm [<xref rid="ref24" ref-type="bibr">24</xref>-<xref rid="ref27" ref-type="bibr">27</xref>]. Nevertheless, in this research, there was no difference in AST/ALT level between the rabbits without treatment and the rabbits with hyperbaric-treatment. In other words, all of those rabbits had no liver function impairment. Research on pigs was subjected left hemihepatectomy suggests that portal vein arterialization promotes early and improved liver regeneration without impairing liver function [<xref rid="ref28" ref-type="bibr">28</xref>].</p></sec><sec sec-type="conclusion" id="sec1-5"><title>Conclusion</title><p>Hind limb ischemia injury reperfusion can trigger a damage for liver morphology, but not lead to liver dysfunction. HBOT for 90 min, 10-60 min after the reperfusion, can protect hepatocytes from damage.</p></sec><sec id="sec1-6"><title>Authors&#x02019; Contributions</title><p>BSL and YM carried out the main research works, WMY performed the statistical analysis and analyzed the main data in the experiments and BSL, WMY and YM approved the final manuscript. All authors read and approved the final manuscript.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors are very thankful to Faculty of Veterinary Medicine, Universitas Airlangga; Department of Surgery, Division of Thoracic, Cardiac, and Vascular Surgery, Dr. Soetomo General Hospital, Surabaya; and the Department of Underwater and Hyperbaric Medicine, Dr. Ramelan Naval Hospital, Surabaya, for providing all the type of facilities to conduct this research.</p></ack><sec id="sec1-7"><title>Competing Interests</title><p>The authors declare that they have no competing interests.</p></sec><ref-list><title>References</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiolet</surname><given-names>J.W.T</given-names></name><name><surname>Baartscheer</surname><given-names>A</given-names></name></person-group><article-title>Update review cellular calcium homeostasis during ischemia:A thermodynamic approach</article-title><source>Cardiovasc. Res</source><year>2000</year><volume>45</volume><fpage>100</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">10728319</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neil-Granger</surname><given-names>D</given-names></name><name><surname>Kvietys</surname><given-names>P.R</given-names></name></person-group><article-title>Reperfusion injury and reactive oxygen species:The evolution of a concept</article-title><source>Redox Biol</source><year>2015</year><volume>6</volume><fpage>524</fpage><lpage>551</lpage><pub-id pub-id-type="pmid">26484802</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaffer</surname><given-names>U</given-names></name><name><surname>Wade</surname><given-names>R.G</given-names></name><name><surname>Gourlay</surname><given-names>T</given-names></name></person-group><article-title>Cytokines in the systemic inflammatory response syndrome:A review</article-title><source>HSR Proc. Intensive Care Cardiovasc. Anesth</source><year>2010</year><volume>2</volume><issue>3</issue><fpage>161</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">23441054</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gyurkovics</surname><given-names>E</given-names></name><name><surname>Aranyi</surname><given-names>P</given-names></name><name><surname>Stangl</surname><given-names>R</given-names></name><name><surname>Onody</surname><given-names>P</given-names></name><name><surname>Ferreira</surname><given-names>G</given-names></name><name><surname>Lotz</surname><given-names>G</given-names></name><name><surname>Kupcsulik</surname><given-names>P</given-names></name><name><surname>Szijarto</surname><given-names>A</given-names></name></person-group><article-title>Post conditioning of the lower limb-protection against the reperfusion syndrome</article-title><source>J. Surg. Res</source><year>2011</year><volume>169</volume><issue>1</issue><fpage>139</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">20085841</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozok</surname><given-names>S</given-names></name><name><surname>Ilhan</surname><given-names>G</given-names></name><name><surname>Yilmaz</surname><given-names>Y</given-names></name><name><surname>Dokumcu</surname><given-names>Z</given-names></name><name><surname>Tumkaya</surname><given-names>L</given-names></name><name><surname>Karamustafa</surname><given-names>H</given-names></name><name><surname>Ozan</surname><given-names>K</given-names></name><name><surname>Karakisi</surname><given-names>S</given-names></name><name><surname>Ergene</surname><given-names>S</given-names></name><name><surname>&#x0015e;ener</surname><given-names>E</given-names></name></person-group><article-title>Protective effects of hyperbaric oxygen and iloprost on ischemia/reperfusion-induced lung injury in a rabbit model</article-title><source>Eur. J. Med. Res</source><year>2012</year><volume>17</volume><issue>1</issue><fpage>14</fpage><pub-id pub-id-type="pmid">22676276</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCormick</surname><given-names>J.G</given-names></name><name><surname>Houle</surname><given-names>T.T</given-names></name><name><surname>Saltzman</surname><given-names>H.A</given-names></name><name><surname>Whaley</surname><given-names>R.C</given-names></name><name><surname>Roy</surname><given-names>R.C</given-names></name></person-group><article-title>Treatment of acute stroke with hyperbaric oxygen:Time window for efficacy</article-title><source>Undersea Hyperb. Med</source><year>2011</year><volume>38</volume><fpage>321</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">22013759</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahmoodzadeh</surname><given-names>S</given-names></name><name><surname>Fliegner</surname><given-names>D</given-names></name><name><surname>Dworatzek</surname><given-names>D</given-names></name></person-group><article-title>Sex differences in animal models for cardiovascular diseases and the role of estrogen</article-title><source>Handb. Exp. Pharmacol</source><year>2012</year><volume>214</volume><fpage>23</fpage><lpage>48</lpage></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Flecknell</surname><given-names>P</given-names></name></person-group><source>Laboratory Animal Anaesthesia</source><year>2009</year><edition>3rd ed</edition><publisher-loc>USA</publisher-loc><publisher-name>Academic Press</publisher-name><fpage>204</fpage><lpage>210</lpage></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunt</surname><given-names>E</given-names></name></person-group><article-title>Grading and staging the histopathological lesions of chronic hepatitis:The knodell histology activity index and beyond</article-title><source>Hepatology</source><year>2000</year><volume>31</volume><fpage>241</fpage><lpage>246</lpage><pub-id pub-id-type="pmid">10613753</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Takacs</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Chang</surname><given-names>Y</given-names></name><name><surname>Candiotii</surname><given-names>K.A</given-names></name></person-group><article-title>The effect of octreotide on hepatic ischemia-reperfusion injury in a rabbit model</article-title><source>Transplant. Proc</source><year>2013</year><volume>45</volume><fpage>2433</fpage><lpage>2438</lpage><pub-id pub-id-type="pmid">23953560</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weigand</surname><given-names>K</given-names></name><name><surname>Brost</surname><given-names>S</given-names></name><name><surname>Steinebrunner</surname><given-names>N</given-names></name><name><surname>Buchler</surname><given-names>M</given-names></name><name><surname>Schemmer</surname><given-names>P</given-names></name><name><surname>Muller</surname><given-names>M</given-names></name></person-group><article-title>Ischemia reperfusion injury in liver surgery and transplantation:Patophysiology</article-title><source>HPB Surg</source><year>2012</year><volume>2012</volume><fpage>1</fpage><lpage>9</lpage></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vali</surname><given-names>L</given-names></name><name><surname>Taba</surname><given-names>G</given-names></name><name><surname>Szentmihalyi</surname><given-names>K</given-names></name><name><surname>Febel</surname><given-names>H</given-names></name><name><surname>Kurucs</surname><given-names>T</given-names></name><name><surname>Pallai</surname><given-names>Z</given-names></name><name><surname>Kupcsulik</surname><given-names>P</given-names></name><name><surname>Blazovics</surname><given-names>A</given-names></name></person-group><article-title>Reduced antioxidant level and increased oxidative damage in intact liver lobes during ischemia reperfusion</article-title><source>World J. Gastroenterol</source><year>2006</year><volume>21</volume><fpage>1086</fpage><lpage>1091</lpage></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansour</surname><given-names>Z</given-names></name><name><surname>Charles</surname><given-names>A.L</given-names></name><name><surname>Kindo</surname><given-names>M</given-names></name><name><surname>Pottecher</surname><given-names>J</given-names></name><name><surname>Chamaraux-Tran</surname><given-names>T.N</given-names></name><name><surname>Lejay</surname><given-names>A</given-names></name><name><surname>Zoll</surname><given-names>J</given-names></name><name><surname>Mazzucotelli</surname><given-names>J.P</given-names></name><name><surname>Geny</surname><given-names>B</given-names></name></person-group><article-title>Remote effects of lower limb ischemia reperfusion:Impaired lung, unchanged liver, and stimulated kidney oxidative capacities</article-title><source>Biomed. Res. Int</source><year>2014</year><volume>4</volume><fpage>390</fpage><lpage>392</lpage></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kao</surname><given-names>M.C</given-names></name><name><surname>Yang</surname><given-names>C.H</given-names></name><name><surname>Chou</surname><given-names>W.C</given-names></name><name><surname>Sheu</surname><given-names>J.R</given-names></name><name><surname>Huang</surname><given-names>C.J</given-names></name></person-group><article-title>Cepharanthine mitigates lung injury in lower limb ischemia-reperfusion</article-title><source>J. Surg. Res</source><year>2015</year><volume>199</volume><fpage>647</fpage><lpage>656</lpage><pub-id pub-id-type="pmid">26193830</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kao</surname><given-names>M.C</given-names></name><name><surname>Chung</surname><given-names>C.Y</given-names></name><name><surname>Chang</surname><given-names>Y.Y</given-names></name><name><surname>Lin</surname><given-names>C.K</given-names></name><name><surname>Sheu</surname><given-names>J.R</given-names></name><name><surname>Huang</surname><given-names>C.J</given-names></name></person-group><article-title>Salutary effects of cepharanthine against skeletal muscle and kidney injuries following limb ischemia/reperfusion</article-title><source>Evid. Based Complement. Alternat. Med</source><year>2015</year><volume>50</volume><fpage>40</fpage><lpage>46</lpage></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duehrkop</surname><given-names>C</given-names></name><name><surname>De noyelle</surname><given-names>J</given-names></name><name><surname>Shaw</surname><given-names>S</given-names></name><name><surname>Rieben</surname><given-names>R</given-names></name></person-group><article-title>Use of dextran sulfate in tourniquet-induced skeletal muscle reperfusion injury</article-title><source>J. Surg. Res</source><year>2014</year><volume>187</volume><fpage>150</fpage><lpage>161</lpage><pub-id pub-id-type="pmid">24176204</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>Y.K</given-names></name><name><surname>Huang</surname><given-names>S.C</given-names></name><name><surname>Kao</surname><given-names>M.C</given-names></name><name><surname>Huang</surname><given-names>C.J</given-names></name></person-group><article-title>Cepharanthine alleviates liver injury in a rodent model of limb ischemia-reperfusion</article-title><source>Acta Anaesthesiologica Taiwanica</source><year>2016</year><volume>54</volume><fpage>11</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">26711228</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serracino-Inglott</surname><given-names>F</given-names></name><name><surname>Habib</surname><given-names>N.A</given-names></name><name><surname>Mathie</surname><given-names>R.T</given-names></name></person-group><article-title>Hepatic ischemia-reperfusion injury</article-title><source>Am. J. Surg</source><year>2001</year><volume>181</volume><fpage>160</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">11425059</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giakoustidis</surname><given-names>D</given-names></name><name><surname>Papageorgiou</surname><given-names>G</given-names></name><name><surname>Iliadis</surname><given-names>S</given-names></name><name><surname>Kontos</surname><given-names>N</given-names></name><name><surname>Kostopoulou</surname><given-names>E</given-names></name><name><surname>Papachrestou</surname><given-names>A</given-names></name><name><surname>Tsantilas</surname><given-names>D</given-names></name><name><surname>Spyridis</surname><given-names>C</given-names></name><name><surname>Takoudas</surname><given-names>D</given-names></name><name><surname>Botsoglou</surname><given-names>N</given-names></name><name><surname>Dimitriadou</surname><given-names>A</given-names></name><name><surname>Giakoustidis</surname><given-names>E</given-names></name></person-group><article-title>Intramuscular administration of very high dose of alpha-tocopherol protects liver from severe ischemia/reperfusion injury</article-title><source>World J. Surg</source><year>2002</year><volume>26</volume><fpage>872</fpage><lpage>877</lpage><pub-id pub-id-type="pmid">11960213</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okaya</surname><given-names>T</given-names></name><name><surname>Lentsch</surname><given-names>A.B</given-names></name></person-group><article-title>Cytokine cascades and the hepatic inflammatory response to ischemia and reperfusion</article-title><source>J. Invest. Surg</source><year>2003</year><volume>16</volume><issue>3</issue><fpage>141</fpage><lpage>143</lpage><pub-id pub-id-type="pmid">12775430</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furukawa</surname><given-names>H</given-names></name><name><surname>Hayashi</surname><given-names>T</given-names></name><name><surname>Todo</surname><given-names>S</given-names></name></person-group><article-title>A novel hydroxyl radical scavenger, nicaraven, protects the liver from warm ischemia and reperfusion injury</article-title><source>Surgery</source><year>2000</year><volume>127</volume><fpage>661</fpage><lpage>669</lpage><pub-id pub-id-type="pmid">10840362</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kihara</surname><given-names>K</given-names></name><name><surname>Ueno</surname><given-names>S</given-names></name><name><surname>Sakoda</surname><given-names>M</given-names></name><name><surname>Aikou</surname><given-names>T</given-names></name></person-group><article-title>Effects of hyperbaric oxygen exposure on experimental hepatic ischemia reperfusion injury:Relationship between its timing and neutrophil sequestration</article-title><source>Liver Transplant</source><year>2005</year><volume>11</volume><fpage>1574</fpage><lpage>1580</lpage></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silveira</surname><given-names>M.R.G</given-names></name><name><surname>Margarido</surname><given-names>M.R</given-names></name><name><surname>Vanni</surname><given-names>J.C</given-names></name><name><surname>Junior</surname><given-names>R.N</given-names></name><name><surname>Silva</surname><given-names>O</given-names></name></person-group><article-title>Effects of hyperbaric oxygen therapy on the liver after injury caused by the hepatic ischemia-reperfusion process</article-title><source>Acta Cir&#x000fa;rgica Brasileira</source><year>2014</year><volume>29</volume><issue>1</issue><fpage>29</fpage><lpage>33</lpage></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chineke</surname><given-names>C.A</given-names></name><name><surname>Ologun</surname><given-names>A.G</given-names></name><name><surname>Ikeobi</surname><given-names>C.O.N</given-names></name></person-group><article-title>Haematological parameters in rabbit breeds and crosses in humid tropics</article-title><source>Pak. J. Biol. Sci</source><year>2006</year><volume>9</volume><fpage>2102</fpage><lpage>2106</lpage></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melillo</surname><given-names>A</given-names></name></person-group><article-title>Rabbit clinical pathology</article-title><source>J. Exot. Pet Med</source><year>2007</year><volume>16</volume><fpage>135</fpage><lpage>145</lpage></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeklova</surname><given-names>E</given-names></name><name><surname>Leva</surname><given-names>L</given-names></name><name><surname>Knotigova</surname><given-names>P</given-names></name><name><surname>Faldyna</surname><given-names>M</given-names></name></person-group><article-title>Age-related changes in selected haematology parameteres in rabbits</article-title><source>Res. Vet. Sci</source><year>2009</year><volume>86</volume><fpage>525</fpage><lpage>528</lpage><pub-id pub-id-type="pmid">19041105</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdel-Azeem</surname><given-names>A.S</given-names></name><name><surname>Abdel-Azim</surname><given-names>A.M</given-names></name><name><surname>Darwish</surname><given-names>A.A</given-names></name><name><surname>Omar</surname><given-names>E.M</given-names></name></person-group><article-title>Haematological and biochemical observations in four pure breeds of rabbits and their crosses under Egyptian environmental conditions</article-title><source>World Rabbit Sci</source><year>2010</year><volume>18</volume><fpage>103</fpage><lpage>110</lpage></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ott</surname><given-names>R</given-names></name><name><surname>Schuppan</surname><given-names>D</given-names></name><name><surname>Tannapfel</surname><given-names>A</given-names></name><name><surname>Wittekind</surname><given-names>C</given-names></name><name><surname>Erhardt</surname><given-names>W</given-names></name><name><surname>Henke</surname><given-names>J</given-names></name><name><surname>Kilic</surname><given-names>N</given-names></name><name><surname>Kockerling</surname><given-names>F</given-names></name><name><surname>Reck</surname><given-names>T</given-names></name><name><surname>Hohenberger</surname><given-names>W</given-names></name><name><surname>Muller</surname><given-names>W</given-names></name></person-group><article-title>Portal vein arterialization as a technical option in liver transplantation:Impact on function, regeneration, and morphology of the liver following hemihepatectomy in pigs</article-title><source>Liver Int</source><year>2003</year><volume>23</volume><fpage>54</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">12640728</pub-id></element-citation></ref></ref-list></back></article>